PPC Stock Analysis: Pilgrims Pride | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 6.536m USD | 12M Return: -45% | US72147K1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.4M
EPS Trend: 67.2%
Qual. Beats: 0
Rev. Trend: 94.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pilgrims Pride Corporation produces, processes, markets, and distributes fresh, frozen, and value-added chicken and pork products, operating across the United States, Europe, and Mexico. The companys product range spans refrigerated whole and cut-up chicken, marinated and non-marinated chicken parts, primary pork cuts, fully cooked and ready-to-cook items, processed sausages, bacon, smoked meats, and prepared foods such as nuggets, patties, and sandwich meats. Beyond traditional animal protein, Pilgrims also offers plant-based proteins, ready-to-eat meals, multi-protein frozen foods, vegetarian items, and desserts. Like most large poultry processors, the business is vertically integrated, controlling stages from breeding and feed milling through processing and distribution, which ties margins to volatile input costs such as corn and soybean meal.
The company sells its products under a wide portfolio of brands, including Pilgrims, Just BARE, Goldn Pump, Gold Kist, County Pride, Pierce Chicken, Pilgrims Mexico, To-Ricos, Del Dia, Moy Park, Mattesons, Richmond, Fridge Raiders, and Denny. Its customer base spans chain restaurants, food processors, broad-line distributors, grocery store chains, wholesale clubs, and other retail and institutional outlets. Founded in 1946 and headquartered in Greeley, Colorado, Pilgrims Pride operates as a subsidiary of JBS N.V., a Brazilian parent that is one of the worlds largest meat processors, giving PPC access to global production, distribution, and procurement capabilities that few independent peers can match.
- Feed grain costs pressure chicken processing margins
- JBS parent capital allocation drives buybacks and dividends
- Avian flu outbreaks disrupt US poultry production and pricing
| Net Income: 545.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -7.84 > 1.0 |
| NWC/Revenue: 5.29% < 20% (prev 9.01%; Δ -3.72% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.22b > Net Income 545.6m |
| Net Debt (2.90b) to EBITDA (1.41b): 2.06 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.8m) vs 12m ago 0.24% < -2% |
| Gross Margin: 9.62% > 18% (prev 13.79%; Δ -4.18% > 0.5%) |
| Asset Turnover: 183.0% > 50% (prev 179.6%; Δ 3.36% > 0%) |
| Interest Coverage Ratio: 5.63 > 6 (EBIT TTM 928.0m / Interest Expense TTM 164.9m) |
| A: 0.10 (Total Current Assets 3.72b - Total Current Liabilities 2.74b) / Total Assets 10.0b |
| B: 0.24 (Retained Earnings 2.36b / Total Assets 10.0b) |
| C: 0.09 (EBIT TTM 928.0m / Avg Total Assets 10.1b) |
| D: 0.60 (Book Value of Equity 3.75b / Total Liabilities 6.27b) |
| Altman-Z'' = 2.65 = A |
| DSRI: 0.76 (Receivables 926.1m/1.21b, Revenue 18.4b/18.2b) |
| GMI: 1.43 (GM 13.79% / 9.62%) |
| AQI: 1.00 (AQ_t 0.23 / AQ_t-1 0.23) |
| SGI: 1.01 (Revenue 18.4b / 18.2b) |
| TATA: -0.07 (NI 545.6m - CFO 1.22b) / TA 10.0b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of August 11, 2026, the stock is trading at USD 26.51 with a total of 1,271,756 shares traded. Over the past week, the price has changed by -5.05%, over one month by -6.16%, over three months by -7.50% and over the past year by -44.99%.
Current recommended Stop Loss: 24.90 (which is 6.1% or 1.4 ATR below the current price).
Pilgrims Pride has received a consensus analysts rating of 3.11. Therefore, it is recommended to hold PPC.
- StrongBuy: 1
- Buy: 0
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 33.4 | 26.1% |
P/E Trailing = 11.9869
P/E Forward = 7.4184
P/S = 0.3545
P/B = 1.7433
P/EG = 0.4882
Revenue TTM = 18.4b USD
EBIT TTM = 928.0m USD
EBITDA TTM = 1.41b USD
Long Term Debt = 2.86b USD (from longTermDebt, last quarter)
Short Term Debt = 913k USD (from shortTermDebt, last quarter)
Debt = 3.30b USD (from shortLongTermDebtTotal, last quarter) + Leases 250.7m
Net Debt = 2.90b USD (calculated: Debt 3.30b - CCE 398.3m)
Enterprise Value = 9.44b USD (6.54b + Debt 3.30b - CCE 398.3m)
Interest Coverage Ratio = 5.63 (Ebit TTM 928.0m / Interest Expense TTM 164.9m)
EV/FCF = 31.01x (Enterprise Value 9.44b / FCF TTM 304.4m)
FCF Yield = 3.22% (FCF TTM 304.4m / Enterprise Value 9.44b)
FCF Margin = 1.65% (FCF TTM 304.4m / Revenue TTM 18.4b)
Net Margin = 2.96% (Net Income TTM 545.6m / Revenue TTM 18.4b)
Gross Margin = 9.62% ((Revenue TTM 18.4b - Cost of Revenue TTM 16.7b) / Revenue TTM)
Gross Margin QoQ = 7.34% (prev 7.62%)
Tobins Q-Ratio = 0.94 (Enterprise Value 9.44b / Total Assets 10.0b)
Interest Expense / Debt = 4.99% (Interest Expense 164.9m / Debt 3.30b)
Taxrate = 30.90% (244.1m / 789.7m)
NOPAT = 641.2m (EBIT 928.0m * (1 - 30.90%))
Current Ratio = 1.36 (Total Current Assets 3.72b / Total Current Liabilities 2.74b)
Debt / Equity = 0.88 (Debt 3.30b / totalStockholderEquity, last quarter 3.75b)
Debt / EBITDA = 2.06 (Net Debt 2.90b / EBITDA 1.41b)
Debt / FCF = 9.54 (Net Debt 2.90b / FCF TTM 304.4m)
Total Stockholder Equity = 3.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.42% (Net Income 545.6m / Total Assets 10.0b)
RoE = 14.85% (Net Income TTM 545.6m / Total Stockholder Equity 3.67b)
RoCE = 14.20% (EBIT 928.0m / Capital Employed (Equity 3.67b + L.T.Debt 2.86b))
RoIC = 9.31% (NOPAT 641.2m / Invested Capital 6.89b)
WACC = 3.81% (E(6.54b)/V(9.84b) * Re(3.99%) + D(3.30b)/V(9.84b) * Rd(4.99%) * (1-Tc(0.31)))
Discount Rate = 3.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 97.59 | Cagr: 0.25%
[DCF] Terminal Value 73.10% ; FCFF base≈622.8m ; Y1≈546.2m ; Y5≈441.3m
[DCF] Fair Price = 17.55 (EV 7.08b - Net Debt 2.90b = Equity 4.18b / Shares 238.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 67.18 | EPS CAGR: 65.77% | SUE: -0.60 | # QB: 0
Revenue Correlation: 94.71 | Revenue CAGR: 2.93% | SUE: -0.56 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.72 | Chg30d=-31.34% | Revisions=-57% | Analysts=4
EPS current Year (2026-12-31): EPS=2.48 | Chg30d=-26.29% | Revisions=-67% | GrowthEPS=-51.9% | GrowthRev=+0.3%
EPS next Year (2027-12-31): EPS=3.03 | Chg30d=-17.93% | Revisions=-67% | GrowthEPS=+22.1% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: -84% (up=0, down=16)